SecBot SecBot
SECBOTREPLAY Home › Report › BLCO

BLCO · Bausch + Lomb announced a board reshuffle at the request of its 87%…

Bausch & Lomb Corp · 8-K filed Aug 6, 2026 at 07:10 ET

At the news

MIXEDIMPACT 5/10

8-K filed Aug 6, 2026 at 07:10 ET

Bausch + Lomb announced a board reshuffle at the request of its 87% owner Bausch Health, replacing four independent directors with four new appointees including Bausch Health's CEO. The company also reported Q2 revenue of $1.394B (+9% YoY) and reaffirmed its raised 2026 guidance. The board changes increase parent-company control and reduce board independence, while the financial results show solid top-line growth and a significant cash-flow improvement.

  • Bausch Health (87% owner) requested and secured the appointment of four new directors, including its own CEO Thomas Appio, replacing four independent directors.
  • Q2 revenue was $1.394B, up 9% reported and 8% constant-currency YoY.
  • Net cash from operations improved from $32M in Q1 to $153M in Q2; adjusted CFO from $45M to $161M.
  • Full-year 2026 guidance reaffirmed: revenue $5.440B–$5.540B, Adjusted EBITDA ex-Acquired IPR&D $1.025B–$1.075B.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access